Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase IV Real World Study on the Use of Low Dose Methoxyflurane (PENTHROX) for the Treatment of Moderate to Severe Trauma Pain in the Canadian Emergency Department

Next Previous
Trial Profile

A Phase IV Real World Study on the Use of Low Dose Methoxyflurane (PENTHROX) for the Treatment of Moderate to Severe Trauma Pain in the Canadian Emergency Department

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Sep 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Methoxyflurane (Primary)
  • Indications Pain
  • Focus Therapeutic Use
  • Acronyms ADVANCE-ED
  • Sponsors Purdue Pharma

Most Recent Events

  • 14 Sep 2021 Status changed from suspended to completed.
  • 24 Jun 2020 Planned End Date changed from 1 Jun 2020 to 1 Sep 2020.
  • 24 Jun 2020 Status changed from active, no longer recruiting to suspended.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top